Table 4.
Potential linear B-cell epitopes identified in each variant predicted by Ellipro.
| Position | Epitope Sequence | Score | Antigenicity |
|---|---|---|---|
| Wuhan Isolate | |||
| 14–28 | QCVNLTTRTQLPPAY | 0.772 | 1.4548 |
| 109–114 | TLDSKT | 0.529 | 1.1073 |
| 1033–1039 | VLGQSKR | 0.523 | 1.6008 |
| England Isolate | |||
| 392–429 | FTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDF | 0.695 | 0.5786 |
| 576–585 | VRDPQTLEIL | 0.644 | 0.5446 |
| 872–928 | QYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFN | 0.649 | 0.5394 |
| USA Isolate | |||
| 392–429 | FTNVYADSFVIRGDEVRQIAPGQTGKIADYNYKLPDDF | 0.695 | 0.5786 |
| 553–565 | TESNKKFLPFQQF | 0.666 | 0.5056 |
| 872–928 | QYTSALLAGTITSGWTFGAGAALQIPFAMQMAYRFNGIGVTQNVLYENQKLIANQFN | 0.649 | 0.5394 |
| 576–585 | VRDPQTLEIL | 0.644 | 0.5449 |
| Indian Isolate | |||
| 239–265 | QTLLALHRSYLTPGDSSSGWTAGAAAY | 0.816 | 0.4822 |
| 14–27 | QCVNLTTRTQLPPA | 0.771 | 1.4983 |
| 64–83 | WFHAGASSGTNGTKRFDNPV | 0.763 | 0.4097 |
| 169–190 | EYVSQPFLMDLEGKQGNFKNLR LIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCT | 0.75 | 0.7830 |
| 118–167 | RFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFK | 0.732 | 0.3023 |
| South African Isolate | |||
| 239–265 | QTLLALHRSYLTPGDSSSGWTAGAAAY | 0.815 | 0.4822 |
| 14–27 | QCVNLTTRTQLPPA | 0.769 | 1.4983 |
| 64–83 | WFHAIHVSGTNGTKRFDNPV | 0.763 | 0.4100 |
| 169–190 | EYVSQPFLMDLEGKQGNFKNLR | 0.75 | 0.7830 |
| 118–167 | LIVNNATNVVIKVCEFQFCNDPFLGVYYHKNNKSWMESEFRVYSSANNCT | 0.731 | 0.1177 |
| 328–378 | RFPNITNLCPFGEVFNATRFASVYAWNRKRISNCVADYSVLYNSASFSTFK | 0.728 | 0.3023 |